calcitonin


Also found in: Thesaurus, Medical, Acronyms, Encyclopedia, Wikipedia.

cal·ci·to·nin

 (kăl′sĭ-tō′nĭn)
n.
A peptide hormone, secreted by the thyroid gland in humans or produced synthetically, that lowers plasma calcium and phosphate levels without augmenting calcium accretion and is used therapeutically to treat diseases such as osteoporosis. Also called thyrocalcitonin.

calcitonin

(ˌkælsɪˈtəʊnɪn)
n
(Biochemistry) a hormone secreted by the thyroid that inhibits the release of calcium from the skeleton and prevents a build-up of calcium in the blood. Also called: thyrocalcitonin Compare parathyroid hormone
[C20: from calci- + ton(ic) + -in]

cal•ci•to•nin

(ˌkæl sɪˈtoʊ nɪn)

n.
a thyroid hormone involved in regulating calcium levels in the blood.
[1960–65; calci- + tone + -in1]

calcitonin

A hormone produced by the thyroid gland. It lowers the calcium level in blood.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.calcitonin - thyroid hormone that tends to lower the level of calcium in the blood plasma and inhibit resorption of bone
thyroid hormone - any of several closely related compounds that are produced by the thyroid gland and are active metabolically
Translations
calcitonina

cal·ci·to·nin

n. calcitonina, hormona segregada por la tiroides que estimula el transporte del calcio de la sangre a los huesos.

calcitonin

n calcitonina
References in periodicals archive ?
There is no cross-reactivity with procalcitonin and calcitonin from other species (pig, salmon, chicken) at concentrations <40 mg/L.
The patient's serum calcitonin level was elevated, however, and a second fine-needle aspiration biopsy sample showed immunoreactivity for calcitonin.
Calcitonin, a polypeptide, is thought to augment bone formation by increasing osteoblast activity, he said.
Calcitonin is a very safe drug that has been widely used for many years and is currently being assayed for the treatment of osteoarthritis and various musculoskeletal clinical painful conditions.
In a Phase III global, randomized, double-blind clinical study in postmenopausal women with osteoporosis known as the ORACAL trial, Tarsa's once-daily oral calcitonin demonstrated superiority to both placebo and commercially-available nasal calcitonin spray in increasing bone mineral density at the lumbar spine after 48 weeks.
The second two-year, Phase III Study 2302, which also assesses safety and efficacy of oral calcitonin in patients with osteoarthritis of the knee, is currently ongoing.
Food and Drug Administration (FDA) for Ostora, its oral calcitonin tablet for the treatment of postmenopausal osteoporosis.
today announced that it presented a new meta-analysis showing that salmon calcitonin does not appear to be associated with an increased risk of cancer in postmenopausal women.
Although expenses have been reduced due to the elimination of our expenditures for the oral calcitonin program, as well as reductions from our recent restructuring, we will need additional sources of cash in order to maintain our future operations.
PINK: UGNE), a leader in the design, delivery, manufacture and development of peptide-based therapeutics, today announced that the Food & Drug Administration (FDA) has posted notice of an Advisory Committee Meeting scheduled on March 5, 2013 to discuss whether the benefit of calcitonin salmon for the treatment of postmenopausal osteoporosis outweighs a potential risk of cancer.
Oral salmon calcitonin, which uses the proprietary absorption enhancing Eligen([R]) Drug Delivery Technology, is being studied in osteoarthritis and osteoporosis by Novartis Pharma AG and Nordic Bioscience.
Poster Presentation at ASBMR 2012 Concludes One-Year Use of Tarsa's Oral Calcitonin Is Not Associated with Increased Risk of Cancer-